Literature DB >> 3928057

Carbamazepine induced systemic lupus erythematosus: case report.

D E Bateman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3928057      PMCID: PMC1417477          DOI: 10.1136/bmj.291.6496.632

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  5 in total

1.  Antinuclear antibodies in patients on anticonvulsant therapy.

Authors:  D Alarcón-Segovia; E Fishbein; P A Reyes; H Díes; S Shwadsky
Journal:  Clin Exp Immunol       Date:  1972-09       Impact factor: 4.330

Review 2.  Drug-induced systemic lupus erythematosus: a critical review.

Authors:  S L Lee; P H CHase
Journal:  Semin Arthritis Rheum       Date:  1975-08       Impact factor: 5.532

3.  [A patient with disseminated lupus erythematosus caused by the use of carbamazepine (Tegretol)].

Authors:  H J Kolstee
Journal:  Ned Tijdschr Geneeskd       Date:  1983-08-27

4.  "Collagen disease" due to carbamazepine (Tegretol).

Authors:  J R Simpson
Journal:  Br Med J       Date:  1966-12-10

5.  Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility.

Authors:  J R Batchelor; K I Welsh; R M Tinoco; C T Dollery; G R Hughes; R Bernstein; P Ryan; P F Naish; G M Aber; R F Bing; G I Russell
Journal:  Lancet       Date:  1980-05-24       Impact factor: 79.321

  5 in total
  3 in total

1.  Clobazam-induced systemic lupus erythematosus.

Authors:  P Caramaschi; D Biasi; A Carletto; T Manzo; L M Bambara
Journal:  Clin Rheumatol       Date:  1995-01       Impact factor: 2.980

2.  [Chest pain, reduced physical activity, and polyserositis in a 35-year old patient with anticonvulsive medication].

Authors:  F Wittchen; S Spencker; S Zinke; N Coban; H P Schultheiss; B Witzenbichler
Journal:  Internist (Berl)       Date:  2006-01       Impact factor: 0.743

Review 3.  Systemic lupus erythematosus (SLE)-like syndromes associated with carbamazepine therapy.

Authors:  K K Jain
Journal:  Drug Saf       Date:  1991 Sep-Oct       Impact factor: 5.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.